Close Menu

A University of Pennsylvania-led team introduces software for teasing out the effects of non-coding variants found in genome-wide association studies. The approach — called "Inferring the molecular mechanisms of noncoding genetic variants," or INFERNO — quantifies tissue-specific enhancers and other regulatory features using statistical methods informed by transcription factor, expression quantitative trait locus, and other functional genomic datasets, the researchers explain.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.